Modified docetaxel, cisplatin and fluorouracil therapy as a first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study

Authors :: Yakup Bozkaya
Gökmen Umut Erdem
Taner Babacan
Sercan Aksoy
Nurullah Zengin
Nuriye Özdemir
Nebi Serkan Demirci
Ibrahim Gullu
Source :: Journal of Clinical Oncology. 34:e17503-e17503
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e17503Background: Modified DCF (mDCF) therapy has been shown to be both a well-tolerated and highly effective regimen for metastatic gastric carcinoma. Here, we investigated the use of mDCF as firs...

Subjects :: Cisplatin
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Head and neck cancer
Retrospective cohort study
medicine.disease
First line treatment
Regimen
Docetaxel
Fluorouracil
Internal medicine
medicine
Basal cell
business
medicine.drug

Full Text Access

Tools